ClinicalTrials.gov record
Completed Phase 1 Interventional

A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies

ClinicalTrials.gov ID: NCT00343798

Public ClinicalTrials.gov record NCT00343798. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 3:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pilot Study to Evaluate the Co-infusion of Ex Vivo Expanded Umbilical Cord Blood Progenitors With an Unmanipulated Cord Blood Graft in Patients Undergoing Umbilical Cord Blood Transplantation for Hematologic Malignancies

Study identification

NCT ID
NCT00343798
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Fred Hutchinson Cancer Center
Other
Enrollment
23 participants

Conditions and interventions

Conditions

Interventions

  • biopsy Procedure
  • cyclophosphamide Drug
  • cyclosporine Drug
  • diagnostic laboratory biomarker analysis Other
  • double-unit umbilical cord blood transplantation Procedure
  • ex-vivo umbilical cord blood expansion Other
  • fludarabine phosphate Drug
  • immunologic technique Other
  • mycophenolate mofetil Drug

Procedure · Drug · Other

Eligibility (public fields only)

Age range
6 Months to 45 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2006
Primary completion
Jun 30, 2013
Completion
Not listed
Last update posted
Feb 10, 2015

Started 2006

United States locations

U.S. sites
4
U.S. states
3
U.S. cities
4
Facility City State ZIP Site status
City of Hope Medical Center Duarte California 91010
University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora Colorado 80045
University of Colorado Denver Colorado 80217-3364
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle Washington 98109

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00343798, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2015 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00343798 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →